Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30058638HIVENSG00000169313.10protein_codingP2RY12NoNo64805Q9H244
TVIS30020716HIVENSG00000169313.10protein_codingP2RY12NoNo64805Q9H244
TVIS30058639HIVENSG00000169313.10protein_codingP2RY12NoNo64805Q9H244
TVIS20036587HPVENSG00000169313.10protein_codingP2RY12NoNo64805Q9H244
TVIS20023553HPVENSG00000169313.10protein_codingP2RY12NoNo64805Q9H244
TCGA Plot Options
Drug Information
GeneP2RY12
DrugBank IDDB01240
Drug NameEpoprostenol
Target IDBE0000110
UniProt IDQ9H244
Regulation Typeagonist
PubMed IDs17155953; 12297509; 20085435
CitationsCattaneo M, Lecchi A: Inhibition of the platelet P2Y12 receptor for adenosine diphosphate potentiates the antiplatelet effect of prostacyclin. J Thromb Haemost. 2007 Mar;5(3):577-82. Epub 2006 Dec 7.@@Yang J, Wu J, Jiang H, Mortensen R, Austin S, Manning DR, Woulfe D, Brass LF: Signaling through Gi family members in platelets. Redundancy and specificity in the regulation of adenylyl cyclase and other effectors. J Biol Chem. 2002 Nov 29;277(48):46035-42. Epub 2002 Sep 23.@@Kobsar AL, Koessler J, Rajkovic MS, Brunner KP, Steigerwald U, Walter U: Prostacyclin receptor stimulation facilitates detection of human platelet P2Y(12) receptor inhibition by the PFA-100 system. Platelets. 2010;21(2):112-6. doi: 10.3109/09537100903440937.
GroupsApproved
Direct Classification
SMILES[H][C@]12C[C@@H](O)[C@H](C=C[C@@H](O)CCCCC)[C@@]1([H])CC(O2)=CCCCC(O)=O
Pathways
PharmGKBPA449479
ChEMBLCHEMBL1139